A detailed history of Td Asset Management Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 227,272 shares of AGIO stock, worth $13.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
227,272
Previous 210,472 7.98%
Holding current value
$13.4 Million
Previous $9.08 Million 11.26%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$41.19 - $49.72 $691,992 - $835,296
16,800 Added 7.98%
227,272 $10.1 Million
Q2 2024

Aug 02, 2024

BUY
$27.55 - $48.83 $1.49 Million - $2.64 Million
54,054 Added 34.56%
210,472 $9.08 Million
Q1 2024

May 08, 2024

BUY
$21.32 - $34.81 $1.37 Million - $2.23 Million
64,200 Added 69.62%
156,418 $4.57 Million
Q3 2023

Oct 27, 2023

BUY
$24.36 - $28.18 $1.06 Million - $1.23 Million
43,719 Added 90.14%
92,218 $2.28 Million
Q1 2023

May 10, 2023

SELL
$21.74 - $30.93 $363,058 - $516,531
-16,700 Reduced 25.61%
48,499 $1.11 Million
Q4 2022

Feb 06, 2023

BUY
$24.81 - $31.52 $233,214 - $296,288
9,400 Added 16.85%
65,199 $1.83 Million
Q3 2022

Nov 07, 2022

SELL
$19.51 - $34.14 $173,639 - $303,846
-8,900 Reduced 13.76%
55,799 $1.59 Million
Q2 2022

Aug 04, 2022

SELL
$17.06 - $31.42 $101,609 - $187,137
-5,956 Reduced 8.43%
64,699 $1.43 Million
Q1 2022

May 10, 2022

SELL
$26.68 - $34.81 $431,148 - $562,529
-16,160 Reduced 18.61%
70,655 $2.06 Million
Q4 2021

Feb 10, 2022

BUY
$29.58 - $49.78 $556,695 - $936,859
18,820 Added 27.68%
86,815 $2.85 Million
Q3 2021

Nov 09, 2021

BUY
$41.92 - $58.18 $159,296 - $221,084
3,800 Added 5.92%
67,995 $3.14 Million
Q2 2021

Aug 11, 2021

SELL
$52.06 - $61.27 $98,341 - $115,739
-1,889 Reduced 2.86%
64,195 $3.09 Million
Q1 2021

May 14, 2021

BUY
$44.23 - $57.5 $350,124 - $455,170
7,916 Added 13.61%
66,084 $3.41 Million
Q4 2020

Feb 16, 2021

SELL
$33.21 - $46.54 $136,161 - $190,814
-4,100 Reduced 6.58%
58,168 $2.52 Million
Q2 2020

Aug 13, 2020

BUY
$34.45 - $53.48 $578,760 - $898,464
16,800 Added 36.95%
62,268 $3.33 Million
Q1 2020

May 15, 2020

BUY
$31.52 - $53.81 $44,128 - $75,334
1,400 Added 3.18%
45,468 $1.61 Million
Q4 2019

Feb 11, 2020

SELL
$30.08 - $50.59 $54,144 - $91,062
-1,800 Reduced 3.92%
44,068 $2.1 Million
Q3 2019

Nov 07, 2019

SELL
$32.4 - $49.58 $51,840 - $79,328
-1,600 Reduced 3.37%
45,868 $1.49 Million
Q2 2019

Aug 01, 2019

SELL
$46.17 - $68.1 $240,084 - $354,119
-5,200 Reduced 9.87%
47,468 $2.37 Million
Q1 2019

May 08, 2019

BUY
$45.92 - $67.67 $508,242 - $748,971
11,068 Added 26.61%
52,668 $3.55 Million
Q4 2018

Feb 01, 2019

SELL
$42.73 - $76.53 $551,217 - $987,237
-12,900 Reduced 23.67%
41,600 $1.92 Million
Q3 2018

Nov 01, 2018

SELL
$71.67 - $91.95 $71,670 - $91,950
-1,000 Reduced 1.8%
54,500 $4.2 Million
Q2 2018

Jul 31, 2018

SELL
$73.22 - $99.55 $212,338 - $288,695
-2,900 Reduced 4.97%
55,500 $4.68 Million
Q1 2018

May 11, 2018

BUY
$59.83 - $86.53 $1.41 Million - $2.04 Million
23,557 Added 67.61%
58,400 $4.78 Million
Q4 2017

Feb 02, 2018

BUY
$52.12 - $72.33 $54,361 - $75,440
1,043 Added 3.09%
34,843 $1.99 Million
Q3 2017

Nov 09, 2017

BUY
$54.89 - $67.12 $1.86 Million - $2.27 Million
33,800
33,800 $2.26 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.